Bharmal, M., Guillemin, I., Marrel, A., Arnould, B., Lambert, J., Hennessy, M., & Fofana, F. (2018). How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial. Orphanet J Rare Dis.

Bharmal, Murtuza, Isabelle Guillemin, Alexia Marrel, Benoit Arnould, Jérémy Lambert, Meliessa Hennessy, ja Fatoumata Fofana. "How to Address the Challenges of Evaluating Treatment Benefits-risks in Rare Diseases? A Convergent Mixed Methods Approach Applied Within a Merkel Cell Carcinoma Phase 2 Clinical Trial." Orphanet J Rare Dis 2018.

Bharmal, Murtuza, et al. "How to Address the Challenges of Evaluating Treatment Benefits-risks in Rare Diseases? A Convergent Mixed Methods Approach Applied Within a Merkel Cell Carcinoma Phase 2 Clinical Trial." Orphanet J Rare Dis 2018.